{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:49:29Z","timestamp":1790401769220,"version":"4.1.0"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TAM receptors, composed of Tyro3, Axl, and Mertk, belong to the receptor tyrosine kinase family and are activated by binding of their cognate ligands, Gas6 and Pros1. These receptor-ligand interactions mediate critical physiological processes, including the maintenance of immunological equilibrium, thrombocyte aggregation and subsequent thrombus development, apoptotic cellular debris clearance, homeostatic regulation of endothelial and vascular smooth muscle cells, and erythrocyte production. Perturbations in TAM signaling cascades have been shown to compromise the clearance of apoptotic cells, leading to persistent inflammatory responses that can contribute to the development of various autoimmune pathologies, including multiple sclerosis, rheumatoid arthritis, Sj\u00f6gren\u2019s syndrome, and systemic lupus erythematosus. We retrieved and reviewed only the primary studies addressing the roles of TAM receptors and their ligands in selected autoimmune diseases from Google Scholar, Scopus, Web of Science, and PubMed. The critical roles of TAM receptors in immune homeostasis and apoptotic cell clearance are well established. However, findings from several primary studies discussed in this review further emphasized that the loss of TAM receptor function in these processes significantly contributes to the pathogenesis and progression of autoimmune diseases. Herein, we highlight the role of TAM receptors in several autoimmune diseases, suggesting that TAM receptors are potential biomarkers for monitoring disease prognosis and therapeutic targets to improve patient outcomes.<\/jats:p>","DOI":"10.1093\/oxfimm\/iqag001","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:39:31Z","timestamp":1768394371000},"source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-9911","authenticated-orcid":false,"given":"Sheu Ibrahim","family":"Adedayo","sequence":"first","affiliation":[{"name":"School of Medicine, Nazarbayev University , Astana, 010000,","place":["Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-0716","authenticated-orcid":false,"given":"Taiye Abdullahi","family":"Gegele","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Morsani College of Medicine, University of South FL , Tampa, FL, 33612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6403-0626","authenticated-orcid":false,"given":"Kehinde Ahmad","family":"Adeshina","sequence":"additional","affiliation":[{"name":"Department of Physiology, Wayne State University School of Medicine , Detroit, MI 48201,","place":["United States"]},{"name":"Department of Physiology, Faculty of Basic Medical Sciences, Federal University of Health Sciences , P.M.B. 45 , 751101,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-8846","authenticated-orcid":false,"given":"Baliqis Adejoke","family":"Olukade","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Morsani College of Medicine, University of South FL , Tampa, FL, 33612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6259-0435","authenticated-orcid":false,"given":"Ridwanullah Abiodun","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Division of Physiology, Southern IL University School of Medicine , Carbondale, IL, 62702,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-2109","authenticated-orcid":false,"given":"Adullateef","family":"Abdulsalam","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University , Astana, 010000,","place":["Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-3394","authenticated-orcid":false,"given":"Toheeb Oladejo","family":"Olalekan","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University , Astana, 010000,","place":["Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5991-4052","authenticated-orcid":false,"given":"Mohamed Mustaf","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, SIMAD University , Mogadishu, 252, Somalia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-580X","authenticated-orcid":false,"given":"Kasimu Ghandi","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Basic Medical and Dental Sciences, Faculty of Dentistry, Zarqa University , P.O. BOX 2000 , Zarqa, 13110,","place":["Jordan"]},{"name":"School of Physiology, Faculty of Health Sciences, University of the Witwatersrand , 7 York Road, Parktown , Johannesburg, 2193,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026030314341883000_iqag001-B1","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J Biol Chem"},{"key":"2026030314341883000_iqag001-B2","doi-asserted-by":"crossref","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026030314341883000_iqag001-B3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/cancers8100097","article-title":"The role of TAM family receptors in immune cell function: implications for cancer therapy","volume":"8","author":"Paolino","year":"2016","journal-title":"Cancers (Basel)"},{"key":"2026030314341883000_iqag001-B4","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.4049\/jimmunol.178.9.5635","article-title":"Macrophages and dendritic cells use different Axl\/Mertk\/Tyro3 receptors in clearance of apoptotic cells","volume":"178","author":"Seitz","year":"2007","journal-title":"J Immunol"},{"key":"2026030314341883000_iqag001-B5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"2026030314341883000_iqag001-B6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/cells7100166","article-title":"The dual role of TAM receptors in autoimmune diseases and cancer: an overview","volume":"7","author":"Wium","year":"2018","journal-title":"Cells"},{"key":"2026030314341883000_iqag001-B7","doi-asserted-by":"crossref","first-page":"e00362","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav"},{"key":"2026030314341883000_iqag001-B8","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.837","article-title":"inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damage","volume":"12","author":"Matute-Blanch","year":"2022","journal-title":"Clin Transl Med"},{"key":"2026030314341883000_iqag001-B9","doi-asserted-by":"crossref","first-page":"7838195","DOI":"10.1155\/2019\/7838195","article-title":"Gas6\/TAM receptors in systemic lupus erythematosus","volume":"2019","author":"Cohen","year":"2019","journal-title":"Dis Markers"},{"key":"2026030314341883000_iqag001-B10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10067-019-04799-5","article-title":"Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus","volume":"39","author":"Liphaus","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026030314341883000_iqag001-B11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2026030314341883000_iqag001-B12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"2026030314341883000_iqag001-B13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"2026030314341883000_iqag001-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coms.2013.09.002","article-title":"Sj\u00f6gren\u2019s syndrome: an update on epidemiology and current insights on pathophysiology","volume":"26","author":"Reksten","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"2026030314341883000_iqag001-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-015-0007-y","article-title":"Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus","volume":"13","author":"Ballantine","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"2026030314341883000_iqag001-B16","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1186\/ar4407","article-title":"Circulating levels of soluble MER in lupus reflect M2c activation of monocytes\/macrophages, autoantibody specificities and disease activity","volume":"15","author":"Zizzo","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2026030314341883000_iqag001-B17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/imr.13267","article-title":"TAM receptors in phagocytosis: Beyond the mere internalisation of particles","volume":"319","author":"Burstyn-Cohen","year":"2023","journal-title":"Immunol Rev"},{"key":"2026030314341883000_iqag001-B18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Advances in Cancer Research"},{"key":"2026030314341883000_iqag001-B19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2026030314341883000_iqag001-B20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/cancers14102488","article-title":"Two-front war on cancer\u2014targeting TAM receptors in solid tumor therapy","volume":"14","author":"Mikolajczyk","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026030314341883000_iqag001-B21","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/emboj.2010.265","article-title":"Tubby and tubby-like protein 1 are new Mertk ligands for phagocytosis","volume":"29","author":"Caberoy","year":"2010","journal-title":"Embo J"},{"key":"2026030314341883000_iqag001-B22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/biom10071035","article-title":"Galectin-3 stimulates tyro3 receptor tyrosine kinase and erk signalling, cell survival and migration in human cancer cells","volume":"10","author":"Al Kafri","year":"2020","journal-title":"Biomolecules"},{"key":"2026030314341883000_iqag001-B23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2026030314341883000_iqag001-B24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.emboj.7600912","article-title":"Structural basis for Gas6\u2013Axl signalling","volume":"25","author":"Sasaki","year":"2006","journal-title":"Embo J"},{"key":"2026030314341883000_iqag001-B25","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/onc.2012.396","article-title":"HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors","volume":"32","author":"Gusenbauer","year":"2013","journal-title":"Oncogene"},{"key":"2026030314341883000_iqag001-B26","doi-asserted-by":"crossref","first-page":"ra66","DOI":"10.1126\/scisignal.2004155","article-title":"The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells","volume":"6","author":"Meyer","year":"2013","journal-title":"Sci Signal"},{"key":"2026030314341883000_iqag001-B27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and Mertk (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol Cancer"},{"key":"2026030314341883000_iqag001-B28","doi-asserted-by":"crossref","first-page":"18355","DOI":"10.1074\/jbc.271.31.18355","article-title":"Identification of the major autophosphorylation sites of Nyk\/Mer, an NCAM-related receptor tyrosine kinase","volume":"271","author":"Ling","year":"1996","journal-title":"J Biol Chem"},{"key":"2026030314341883000_iqag001-B29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol Cancer"},{"key":"2026030314341883000_iqag001-B30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsb971","article-title":"Structural basis of membrane binding by Gla domains of vitamin K\u2013dependent proteins","volume":"10","author":"Huang","year":"2003","journal-title":"Nat Struct Biol"},{"key":"2026030314341883000_iqag001-B31","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1111\/j.1742-4658.2006.05529.x","article-title":"Gas6 and protein S: vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily","volume":"273","author":"Hafizi","year":"2006","journal-title":"Febs J"},{"key":"2026030314341883000_iqag001-B32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","article-title":"A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation","volume":"109","author":"Sather","year":"2007","journal-title":"Blood"},{"key":"2026030314341883000_iqag001-B33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2019.01.007","article-title":"effect of soluble cleavage products of important receptors\/ligands on efferocytosis: their role in inflammatory, autoimmune and cardiovascular disease","volume":"50","author":"Tajbakhsh","year":"2019","journal-title":"Ageing Res Rev"},{"key":"2026030314341883000_iqag001-B34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026030314341883000_iqag001-B35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"2026030314341883000_iqag001-B36","first-page":"e8094","article-title":"The prevalence of autoimmune disorders in women: a narrative review","volume":"12","author":"Angum","year":"2020","journal-title":"Cureus"},{"key":"2026030314341883000_iqag001-B37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/eva.13167","article-title":"Why women have more autoimmune diseases than men: an evolutionary perspective","volume":"14","author":"Kronzer","year":"2021","journal-title":"Evol Appl"},{"key":"2026030314341883000_iqag001-B38","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"JAMA"},{"key":"2026030314341883000_iqag001-B39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: Insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"key":"2026030314341883000_iqag001-B40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(18)30451-4","article-title":"Association between pathological and MRI findings in multiple sclerosis","volume":"18","author":"Filippi","year":"2019","journal-title":"Lancet Neurol"},{"key":"2026030314341883000_iqag001-B41","first-page":"572","article-title":"Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology","volume":"26","author":"Geurts","year":"2005","journal-title":"Ajnr Am J Neuroradiol"},{"key":"2026030314341883000_iqag001-B42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"B\u00f8","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026030314341883000_iqag001-B43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.msard.2011.09.002","article-title":"Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond","volume":"1","author":"Kipp","year":"2012","journal-title":"Mult Scler Relat Disord"},{"key":"2026030314341883000_iqag001-B44","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"2026030314341883000_iqag001-B45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11882-023-01102-0","article-title":"Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches","volume":"23","author":"Vasileiou","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026030314341883000_iqag001-B46","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/glia.22597","article-title":"Mechanisms of white matter damage in multiple sclerosis","volume":"62","author":"Lassmann","year":"2014","journal-title":"Glia"},{"key":"2026030314341883000_iqag001-B47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2015.00636","article-title":"B-cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation","volume":"6","author":"Michel","year":"2015","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"2026030314341883000_iqag001-B49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"2026030314341883000_iqag001-B50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","article-title":"Pathogenesis of tissue injury in MS lesions","volume":"98","author":"Trapp","year":"1999","journal-title":"J Neuroimmunol"},{"key":"2026030314341883000_iqag001-B51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1750-3639.1999.tb00547.x","article-title":"Axonal pathology in multiple sclerosis. A historical note","volume":"9","author":"Kornek","year":"1999","journal-title":"Brain Pathol"},{"key":"2026030314341883000_iqag001-B52","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030314341883000_iqag001-B53","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1038\/s41598-019-44615-3","article-title":"Gray matter alterations in early and late relapsing-remitting multiple sclerosis evaluated with synthetic quantitative magnetic resonance imaging","volume":"9","author":"Andica","year":"2019","journal-title":"Sci Rep"},{"key":"2026030314341883000_iqag001-B54","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.20112","article-title":"Sodium channels contribute to microglia\/macrophage activation and function in EAE and MS","volume":"49","author":"Craner","year":"2005","journal-title":"Glia"},{"key":"2026030314341883000_iqag001-B55","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","article-title":"Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, doubleblind, placebo-controlled, parallel-group trial","volume":"9","author":"Kapoor","year":"2010","journal-title":"Lancet Neurol"},{"key":"2026030314341883000_iqag001-B56","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bcp.2011.07.092","article-title":"Redox regulation of cellular stress response in multiple sclerosis","volume":"82","author":"Pennisi","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"2026030314341883000_iqag001-B57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0097-7","article-title":"Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?","volume":"2","author":"Lee","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"2026030314341883000_iqag001-B58","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"2026030314341883000_iqag001-B59","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"2026030314341883000_iqag001-B60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","article-title":"Grey matter pathology in multiple sclerosis","volume":"7","author":"Geurts","year":"2008","journal-title":"Lancet Neurol"},{"key":"2026030314341883000_iqag001-B61","first-page":"1118180","article-title":"Systemic lupus erythematosus-predisposition factors, pathogenesis, diagnosis, treatment and disease models","volume-title":"Front Immunol","author":"Nandakumar","year":"2022"},{"key":"2026030314341883000_iqag001-B62","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026030314341883000_iqag001-B63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"2026030314341883000_iqag001-B64","doi-asserted-by":"crossref","first-page":"668007","DOI":"10.3389\/fimmu.2021.668007","article-title":"Comparative analysis on abnormal methylome of differentially expressed genes and disease pathways in the immune cells of RA and SLE","volume":"12","author":"Fang","year":"2021","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature09370","article-title":"inhibition of follicular T-helper cells by CD8+ regulatory T-cells is essential for self tolerance","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"2026030314341883000_iqag001-B66","doi-asserted-by":"crossref","first-page":"922958","DOI":"10.3389\/fimmu.2022.922958","article-title":"Helios expression is downregulated on CD8+ Treg in two mouse models of lupus during disease progression","volume":"13","author":"Par\u00eds-Mu\u00f1oz","year":"2022","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2011.00063","article-title":"Marginal zone B-cells, a gatekeeper of innate immunity","volume":"2","author":"Zouali","year":"2011","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B68","doi-asserted-by":"crossref","first-page":"814857","DOI":"10.3389\/fimmu.2022.814857","article-title":"The role of B1 cells in systemic lupus erythematosus","volume":"13","author":"She","year":"2022","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","volume":"23","author":"Jang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026030314341883000_iqag001-B70","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030314341883000_iqag001-B71","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10787-024-01445-8","article-title":"Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview","volume":"32","author":"Kaur","year":"2024","journal-title":"Inflammopharmacology"},{"key":"2026030314341883000_iqag001-B72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026030314341883000_iqag001-B73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","article-title":"Innate immunity and rheumatoid arthritis","volume":"36","author":"Gierut","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"2026030314341883000_iqag001-B74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","article-title":"Nonclassical monocytes in health and disease","volume":"37","author":"Narasimhan","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"2026030314341883000_iqag001-B75","doi-asserted-by":"crossref","first-page":"102382","DOI":"10.1016\/j.jaut.2019.102382","article-title":"Innate immunity as the trigger of systemic autoimmune diseases","volume":"110","author":"Saferding","year":"2020","journal-title":"J Autoimmun"},{"key":"2026030314341883000_iqag001-B76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bj.2020.06.010","article-title":"Innate immunity drives pathogenesis of rheumatoid arthritis","volume":"44","author":"Edilova","year":"2021","journal-title":"Biomed J"},{"key":"2026030314341883000_iqag001-B77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JIR.S277457","article-title":"role of caspase-1 in the pathogenesis of inflammatory-associated chronic noncommunicable diseases","volume":"13","author":"Molla","year":"2020","journal-title":"J Inflamm Res"},{"key":"2026030314341883000_iqag001-B78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026030314341883000_iqag001-B79","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2019.01255","article-title":"Targeting macrophages: friends or foes in disease?","volume":"10","author":"Ardura","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026030314341883000_iqag001-B80","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcp.2019.03.029","article-title":"The many facets of macrophages in rheumatoid arthritis","volume":"165","author":"Siouti","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2026030314341883000_iqag001-B81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"2026030314341883000_iqag001-B82","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00018-019-03235-w","article-title":"CCL21\/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis","volume":"77","author":"Van Raemdonck","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"2026030314341883000_iqag001-B83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","article-title":"Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis","volume":"455","author":"Mateen","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2026030314341883000_iqag001-B84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/BOR.0000000000000470","article-title":"What are the dominant cytokines in early rheumatoid arthritis?","volume":"30","author":"Ridgley","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2026030314341883000_iqag001-B85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.31138\/mjr.29.4.193","article-title":"Update on Sj\u00f6gren\u2019s syndrome 2018","volume":"29","author":"Argyropoulou","year":"2018","journal-title":"Mediterr J Rheumatol"},{"key":"2026030314341883000_iqag001-B86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-014-3072-5","article-title":"Sj\u00f6gren\u2019s syndrome: still not fully understood disease","volume":"35","author":"Ma\u015bli\u0144ska","year":"2015","journal-title":"Rheumatol Int"},{"key":"2026030314341883000_iqag001-B87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2017.04.018","article-title":"Genetics of Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Teos","year":"2017","journal-title":"Clin Immunol"},{"key":"2026030314341883000_iqag001-B88","first-page":"2211","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2022","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026030314341883000_iqag001-B89","doi-asserted-by":"crossref","first-page":"684999","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of B-cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B90","doi-asserted-by":"crossref","first-page":"792593","DOI":"10.3389\/fmed.2021.792593","article-title":"recent advances of salivary gland biopsy in Sj\u00f6gren\u2019s syndrome","volume":"8","author":"Liao","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026030314341883000_iqag001-B91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/cei\/uxac090","article-title":"Cytokine production by human B-cells: role in health and autoimmune disease","volume":"210","author":"de Gruijter","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2026030314341883000_iqag001-B92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1573397112666160714164149","article-title":"Update on pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Sandhya","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"2026030314341883000_iqag001-B93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J Autoimmun"},{"key":"2026030314341883000_iqag001-B94","doi-asserted-by":"crossref","first-page":"102335","DOI":"10.1016\/j.jaut.2019.102335","article-title":"Autoimmune epithelitis (Sj\u00f6gren\u2019s syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity","volume":"104","author":"Katsiougiannis","year":"2019","journal-title":"J Autoimmun"},{"key":"2026030314341883000_iqag001-B95","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.3390\/ijms21239172","article-title":"Innate immunity and biological therapies for the treatment of Sj\u00f6gren\u2019s syndrome","volume":"21","author":"Srivastava","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026030314341883000_iqag001-B96","first-page":"1884","article-title":"Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sj\u00f6gren\u2019s syndrome","volume":"29","author":"Tsunawaki","year":"2002","journal-title":"J Rheumatol"},{"key":"2026030314341883000_iqag001-B97","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0","article-title":"\"Lymphoid\" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sj\u00f6gren\u2019s syndrome patients: possible participation in lymphoid structure formation","volume":"44","author":"Xanthou","year":"2001","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"2026030314341883000_iqag001-B98","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","article-title":"involvement of the interferon-\u03b3\u2013induced T-cell\u2013attracting chemokines, interferon-\u03b3\u2013inducible 10-kd protein (CXCL10) and monokine induced by interferon-\u03b3 (CXCL9), in the salivary gland lesions of patients with Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Ogawa","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2026030314341883000_iqag001-B99","doi-asserted-by":"crossref","first-page":"12903","DOI":"10.3390\/ijms222312903","article-title":"Salivary biomarkers in patients with sj\u00f6gren\u2019s syndrome\u2014a systematic review","volume":"22","author":"Jung","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026030314341883000_iqag001-B100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12974-017-0796-7","article-title":"Interleukin-1 as a mediator of fatigue in disease: a narrative review","volume":"14","author":"Roerink","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2026030314341883000_iqag001-B101","doi-asserted-by":"crossref","first-page":"102756","DOI":"10.1016\/j.autrev.2021.102756","article-title":"Pathophysiologic role of Interleukin-33\/ST2 in Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Soyfoo","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2026030314341883000_iqag001-B102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol Rev"},{"key":"2026030314341883000_iqag001-B103","doi-asserted-by":"crossref","first-page":"107893","DOI":"10.1016\/j.pharmthera.2021.107893","article-title":"Resolving inflammation by TAM receptor activation","volume":"227","author":"Vago","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2026030314341883000_iqag001-B104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","article-title":"The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells","volume":"19","author":"Zveik","year":"2024","journal-title":"Mol Neurodegener"},{"key":"2026030314341883000_iqag001-B105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1061663","article-title":"Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family","volume":"293","author":"Lu","year":"2001","journal-title":"Science"},{"key":"2026030314341883000_iqag001-B106","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/glia.23481","article-title":"The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system","volume":"66","author":"Blades","year":"2018","journal-title":"Glia"},{"key":"2026030314341883000_iqag001-B107","doi-asserted-by":"crossref","first-page":"e1009176","DOI":"10.1371\/journal.ppat.1009176","article-title":"GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection","volume":"16","author":"Ortiz Wilczy\u00f1ski","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026030314341883000_iqag001-B108","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/cells9081779","article-title":"Gas6 induces myelination through anti-inflammatory IL-10 and TGF-\u03b2 upregulation in white matter and glia","volume":"9","author":"Goudarzi","year":"2020","journal-title":"Cells"},{"key":"2026030314341883000_iqag001-B109","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/glia.24534","article-title":"The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3","volume":"72","author":"Asadian","year":"2024","journal-title":"Glia"},{"key":"2026030314341883000_iqag001-B110","doi-asserted-by":"crossref","first-page":"578016","DOI":"10.1016\/j.jneuroim.2023.578016","article-title":"TAM receptor signaling dictates lesion location and clinical phenotype during experimental autoimmune encephalomyelitis","volume":"375","author":"Gardner","year":"2023","journal-title":"J Neuroimmunol"},{"key":"2026030314341883000_iqag001-B111","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1523\/JNEUROSCI.1180-08.2008","article-title":"Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination","volume":"28","author":"Binder","year":"2008","journal-title":"J Neurosci"},{"key":"2026030314341883000_iqag001-B112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.08.076","article-title":"Axl\u2212\/\u2212 mice have delayed recovery and prolonged axonal damage following cuprizone toxicity","volume":"1240","author":"Hoehn","year":"2008","journal-title":"Brain Res"},{"key":"2026030314341883000_iqag001-B113","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2353\/ajpath.2009.080807","article-title":"Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions","volume":"175","author":"Weinger","year":"2009","journal-title":"Am J Pathol"},{"key":"2026030314341883000_iqag001-B114","doi-asserted-by":"crossref","first-page":"e15748","DOI":"10.1371\/journal.pone.0015748","article-title":"GAS6 enhances repair following cuprizone-induced demyelination","volume":"5","author":"Tsiperson","year":"2010","journal-title":"PLoS One"},{"key":"2026030314341883000_iqag001-B115","doi-asserted-by":"crossref","first-page":"e17727","DOI":"10.1371\/journal.pone.0017727","article-title":"Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination","volume":"6","author":"Binder","year":"2011","journal-title":"PloS One"},{"key":"2026030314341883000_iqag001-B116","doi-asserted-by":"crossref","first-page":"e16964","DOI":"10.1371\/journal.pone.0016964","article-title":"Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"key":"2026030314341883000_iqag001-B117","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-2094-8-49","article-title":"loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis","volume":"8","author":"Weinger","year":"2011","journal-title":"J Neuroinflammation"},{"key":"2026030314341883000_iqag001-B118","doi-asserted-by":"crossref","first-page":"406483","DOI":"10.1155\/2013\/406483","article-title":"Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis","volume":"2013","author":"Sainaghi","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2026030314341883000_iqag001-B119","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1523\/JNEUROSCI.2449-14.2014","article-title":"Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis","volume":"34","author":"Gruber","year":"2014","journal-title":"J Neurosci"},{"key":"2026030314341883000_iqag001-B120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/brain\/awu408","article-title":"New candidates for CD4 T-cell pathogenicity in experimental neuroinflammation and multiple sclerosis","volume":"138","author":"Hoppmann","year":"2015","journal-title":"Brain"},{"key":"2026030314341883000_iqag001-B121","first-page":"2055217315596532","article-title":"Association of plasma levels of Protein S with disease severity in multiple sclerosis","volume":"1","author":"Ma","year":"2015","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"2026030314341883000_iqag001-B122","doi-asserted-by":"crossref","first-page":"e1005853","DOI":"10.1371\/journal.pgen.1005853","article-title":"Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1* 15: 01 status","volume":"12","author":"Binder","year":"2016","journal-title":"PLoS Genet"},{"key":"2026030314341883000_iqag001-B123","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/glia.23214","article-title":"Loss of G as6 and A xl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure","volume":"65","author":"Ray","year":"2017","journal-title":"Glia"},{"key":"2026030314341883000_iqag001-B124","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1212\/NXI.0000000000000402","article-title":"Mertk-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS","volume":"4","author":"Healy","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026030314341883000_iqag001-B125","doi-asserted-by":"crossref","first-page":"1362960","DOI":"10.3389\/fimmu.2024.1362960","article-title":"Gas6\/TAM system as potential biomarker for multiple sclerosis prognosis","volume":"15","author":"D\u2019Onghia","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"2026030314341883000_iqag001-B126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-023-02921-8","article-title":"Mertk-expressing microglia influence oligodendrogenesis and myelin modelling in the CNS","volume":"20","author":"Nguyen","year":"2023","journal-title":"J Neuroinflammation"},{"key":"2026030314341883000_iqag001-B127","doi-asserted-by":"crossref","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","article-title":"Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination","volume":"34","author":"Shen","year":"2021","journal-title":"Cell Rep"},{"key":"2026030314341883000_iqag001-B128","doi-asserted-by":"crossref","first-page":"176600","DOI":"10.1016\/j.ejphar.2024.176600","article-title":"Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor","volume":"973","author":"Liu","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"2026030314341883000_iqag001-B129","doi-asserted-by":"crossref","first-page":"3205176","DOI":"10.1155\/2020\/3205176","article-title":"Tyrosine kinase receptors Axl and Mertk mediate the beneficial effect of electroacupuncture in a cuprizone-induced demyelinating model","volume":"2020","author":"Zou","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"2026030314341883000_iqag001-B130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/imcb.70054","article-title":"Tyro3 deletion is protective in experimental autoimmune encephalomyelitis","volume":"103","author":"Binder","year":"2025","journal-title":"Immunol Cell Biol"},{"key":"2026030314341883000_iqag001-B131","doi-asserted-by":"crossref","first-page":"156544","DOI":"10.1016\/j.phymed.2025.156544","article-title":"Novel anti-inflammatory compounds that alleviate experimental autoimmune encephalomyelitis","volume":"139","author":"Sun","year":"2025","journal-title":"Phytomedicine"},{"key":"2026030314341883000_iqag001-B132","doi-asserted-by":"crossref","first-page":"1548269","DOI":"10.3389\/fchem.2025.1548269","article-title":"Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management","volume":"13","author":"Shreevatsa","year":"2025","journal-title":"Front Chem"},{"key":"2026030314341883000_iqag001-B133","doi-asserted-by":"crossref","first-page":"106635","DOI":"10.1016\/j.msard.2025.106635","article-title":"A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapy","volume":"102","author":"Chu","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"2026030314341883000_iqag001-B134","doi-asserted-by":"crossref","first-page":"2180708","DOI":"10.1155\/2020\/2180708","article-title":"Anti-Tyro3 IgG associates with disease activity and reduces efferocytosis of macrophages in new-onset systemic lupus erythematosus","volume":"2020","author":"Zhou","year":"2020","journal-title":"J Immunol Res"},{"key":"2026030314341883000_iqag001-B135","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1177\/09612033211016100","article-title":"Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium","volume":"30","author":"Soliman","year":"2021","journal-title":"Lupus"},{"key":"2026030314341883000_iqag001-B136","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001407","article-title":"Expression pattern and clinical significance of MerTK on circulating NK cells in systemic lupus erythematosus","volume":"12","author":"Liang","year":"2025","journal-title":"Lupus Sci Med"},{"key":"2026030314341883000_iqag001-B137","doi-asserted-by":"crossref","first-page":"1524315","DOI":"10.3389\/fimmu.2025.1524315","article-title":"hydroxychloroquine enhances efferocytosis and modulates inflammation via MerTK\/Gas6 signaling in a pristane-induced lupus mouse model","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"2026030314341883000_iqag001-B138","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/ar3316","article-title":"Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2026030314341883000_iqag001-B139","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10067-012-2027-z","article-title":"Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus","volume":"31","author":"Wu","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2026030314341883000_iqag001-B140","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10875-012-9743-7","article-title":"Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease","volume":"32","author":"Gheita","year":"2012","journal-title":"J Clin Immunol"},{"key":"2026030314341883000_iqag001-B141","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10875-012-9765-1","article-title":"serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus","volume":"33","author":"Kim","year":"2013","journal-title":"J Clin Immunol"},{"key":"2026030314341883000_iqag001-B142","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/ar4199","article-title":"Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity","volume":"15","author":"Recarte-Pelz","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2026030314341883000_iqag001-B143","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00296-013-2882-1","article-title":"Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis","volume":"34","author":"Wu","year":"2014","journal-title":"Rheumatol Int"},{"key":"2026030314341883000_iqag001-B144","doi-asserted-by":"crossref","first-page":"431896","DOI":"10.1155\/2014\/431896","article-title":"The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus","volume":"2014","author":"Zhu","year":"2014","journal-title":"J Immunol Res"},{"key":"2026030314341883000_iqag001-B145","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar4517","article-title":"Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy","volume":"16","author":"Hilliard","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2026030314341883000_iqag001-B146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejr.2014.07.003","article-title":"Serum growth arrest specific protein 6 and its receptor (Axl) in SLE patients","volume":"37","author":"Bakr","year":"2015","journal-title":"Egypt Rheumatol"},{"key":"2026030314341883000_iqag001-B147","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.2843","volume-title":"THU0500 Soluble TAM (TYRO3, AXL, MER) Receptors and GAS6 Ligand in Patients with Juvenile Systemic Lupus Erythematosus (JSLE)","author":"Liphaus","year":"2015"},{"key":"2026030314341883000_iqag001-B148","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","article-title":"Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE","volume":"169","author":"Orme","year":"2016","journal-title":"Clin Immunol"},{"key":"2026030314341883000_iqag001-B149","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/acr.22835","article-title":"Axl, ferritin, insulin-like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus","volume":"68","author":"Mok","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026030314341883000_iqag001-B150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.37786","article-title":"Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis","volume":"65","author":"van den Brand","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026030314341883000_iqag001-B151","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.4902","volume-title":"FRI0037 Mer-Mediated Efferocytosis Tempers Arthritis by Preventing Neutrophils to Go into Secondary Necrosis and Spill Their Inflammatory Content in the Joint","author":"Waterborg","year":"2017"},{"key":"2026030314341883000_iqag001-B152","doi-asserted-by":"crossref","first-page":"e0205902","DOI":"10.1371\/journal.pone.0205902","article-title":"Tyro3\/Axl\/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis","volume":"13","author":"Waterborg","year":"2018","journal-title":"PLoS One"},{"key":"2026030314341883000_iqag001-B153","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1756-185X.12367","article-title":"Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor A xl in patients with rheumatoid arthritis","volume":"20","author":"Bassyouni","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2026030314341883000_iqag001-B154","doi-asserted-by":"crossref","first-page":"117.7","DOI":"10.4049\/jimmunol.196.Supp.117.7","article-title":"The TAM receptors Axl and Mer play a joint-specific protective role in experimental arthritis","volume":"196","author":"Waterborg","year":"2016","journal-title":"The Journal of Immunology"},{"key":"2026030314341883000_iqag001-B155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/key337","article-title":"The level of synovial AXL expression determines the outcome of inflammatory arthritis, possibly depending on the upstream role of TGF-\u03b21","volume":"58","author":"Waterborg","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026030314341883000_iqag001-B156","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41467-024-46564-6","article-title":"Axl and Mertk regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis","volume":"15","author":"Nerviani","year":"2024","journal-title":"Nat Commun"},{"key":"2026030314341883000_iqag001-B157","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12964-023-01133-0","article-title":"Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2026030314341883000_iqag001-B158","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cei\/uxac071","article-title":"Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis","volume":"209","author":"Zheng","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2026030314341883000_iqag001-B159","doi-asserted-by":"crossref","first-page":"109753","DOI":"10.1016\/j.clim.2023.109753","article-title":"Tyro3 receptor tyrosine kinase contributes to pathogenic phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis and disturbs immune cell balance in experimental arthritis","volume":"255","author":"Wang","year":"2023","journal-title":"Clin Immunol"},{"key":"2026030314341883000_iqag001-B160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/annrheumdis-2012-202907","article-title":"Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis","volume":"73","author":"Ruiz-Heiland","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026030314341883000_iqag001-B161","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-eular.636","volume-title":"Ab0046 the Expression and Clinical Significance of Tam Receptor Tyrosine Kinase on Monocyte Subsets in Rheumatoid Arthritis","author":"Xue","year":"2021"},{"key":"2026030314341883000_iqag001-B162","doi-asserted-by":"crossref","first-page":"92","DOI":"10.33590\/emjrheumatol\/10314099","article-title":"editor\u2019s pick: tyro3, axl, and Mertk receptor tyrosine kinases: is there evidence of direct involvement in development and onset of sj\u00f6gren\u2019s syndrome?","volume":"3","author":"Wanchoo","year":"2016","journal-title":"EMJ Rheumatol"},{"key":"2026030314341883000_iqag001-B163","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"prevalence of interferon type I signature in CD14 monocytes of patients with Sj\u00f6gren\u2019s syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026030314341883000_iqag001-B164","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","article-title":"Activation of the type I interferon pathway in primary Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Mavragani","year":"2010","journal-title":"J Autoimmun"},{"key":"2026030314341883000_iqag001-B165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jbspin.2015.01.008","article-title":"The association of Tyro3\/Axl\/Mer signaling with inflammatory response, disease activity in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"82","author":"Qin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"2026030314341883000_iqag001-B166","doi-asserted-by":"crossref","first-page":"e0139955","DOI":"10.1371\/journal.pone.0139955","article-title":"Growth arrest-specific 6 protein in patients with Sj\u00f6gren syndrome: determination of the plasma level and expression in the labial salivary gland","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2026030314341883000_iqag001-B167","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.3390\/ijms22189711","article-title":"Defective efferocytosis in a murine model of Sj\u00f6gren\u2019s syndrome is mediated by dysfunctional mer tyrosine kinase receptor","volume":"22","author":"Witas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026030314341883000_iqag001-B168","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2024-eular.2493","volume-title":"AB0820 Clinical Significance of Mertk and Tyro3 Levels in the Minor Salivary Glands of Patients with Sj\u00f6gren\u2019s Syndrome","author":"Lee","year":"2024"},{"key":"2026030314341883000_iqag001-B169","doi-asserted-by":"crossref","first-page":"23065","DOI":"10.1038\/s41598-025-08086-z","article-title":"Clinical significance of TAM receptor in the minor salivary glands of patients with Sj\u00f6gren\u2019s disease","volume":"15","author":"Choi","year":"2025","journal-title":"Sci Rep"}],"container-title":["Oxford Open Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ooim\/advance-article-pdf\/doi\/10.1093\/oxfimm\/iqag001\/66540397\/iqag001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag001\/66540397\/iqag001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag001\/66540397\/iqag001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:34:43Z","timestamp":1772566483000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ooim\/article\/doi\/10.1093\/oxfimm\/iqag001\/8438356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfimm\/iqag001","relation":{},"ISSN":["2633-6960"],"issn-type":[{"value":"2633-6960","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"iqag001"}}